INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 3 analysts with an average price target of $3.6. This is a potential upside of $69.32 (197.52%) from yesterday's end of day stock price of $1.21.

Inovio Pharmaceuticals's activity chart (see below) currently has 49 price targets and 46 ratings on display. The stock rating distribution of INO is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.28% with an average time for these price targets to be met of 421.03 days.

Highest price target for INO is $6, Lowest price target is $1.8, average price target is $3.6.

Most recent stock forecast was given by from PIPER SANDLER on 14-Nov-2025. First documented stock forecast 21-Apr-2015.

Currently out of the existing stock ratings of INO, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Jul-2025

$6

$4.9 (445.45%)

$5

7 months 24 days ago
(14-Nov-2025)

0/2 (0%)

$3.95 (192.68%)

Hold Since 13-Jan-2025

$3

$1.9 (172.73%)

$3

10 months 24 days ago
(14-Aug-2025)

0/3 (0%)

$1.38 (85.19%)

Buy Since 13-Aug-2025

$1.8

$0.7 (63.64%)

$4.8

10 months 25 days ago
(13-Aug-2025)

2/2 (100%)

$0.1 (5.88%)

4

Buy Since 12-Aug-2024

$15

1 years 1 months 24 days ago
(14-May-2025)

0/2 (0%)

$10.92 (267.65%)

Buy Since 04-Jan-2024

$12

1 years 1 months 24 days ago
(14-May-2025)

0/2 (0%)

$10.04 (512.24%)

Show more analysts

Please expand the browser size to see the chart

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 421.03 days on average for the stock forecasts to be realized with a an average price target met ratio 60.28

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

GLEN SANTANGELO

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Glen Santangelo works at BARCLAYS and has 10 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Aydin Huseynov with highest potential upside - $2158.39

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jonathan Aschoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?